The INPP5F Antibody, Biotin conjugated is a specialized immunological reagent designed for detecting the INPP5F protein, a phosphoinositide 4-phosphatase involved in cellular membrane trafficking and phosphoinositide metabolism. This antibody is conjugated with biotin, enabling its use in high-sensitivity assays like enzyme-linked immunosorbent assays (ELISA) and immunoprecipitation via streptavidin-based detection systems.
Target Protein: INPP5F (Sac2), a 4-phosphatase that regulates phosphatidylinositol 4-phosphate (PI4P) levels in early endosomes .
Conjugation: Biotin allows for versatile detection using streptavidin-horseradish peroxidase (HRP) or fluorescent streptavidin in downstream assays.
Applications: Validated for ELISA, Western blot (WB), and immunofluorescence (IF) in human and murine samples .
Detects INPP5F in lysates of cells with endosomal defects (e.g., Rab5-positive compartments) .
Example: In studies of hepatocellular carcinoma (HCC), this antibody confirmed INPP5F overexpression in tumor tissues (TCGA-LIHC cohort) .
Localizes INPP5F to early endosomes (co-staining with Rab5/EEA1 markers) .
Application: Visualizing INPP5F translocation in HCC cells (cytoplasmic vs. nuclear) .
Sac2/INPP5F interacts with OCRL in Rab5-positive endosomes to regulate PI(4,5)P₂ metabolism .
Knockout models (Sac2 KO MEFs) exhibit impaired transferrin internalization, highlighting its role in clathrin-mediated endocytosis .
Overexpression in HCC correlates with poor prognosis and promotes aerobic glycolysis via Notch signaling .
Mechanism: INPP5F interacts with ASPH to activate c-MYC and cyclin E1, enhancing tumor growth .
Sac2 deletion in mice enhances axon regeneration post-spinal cord injury (SCI) by modulating membrane trafficking .
Safety Profile: No adverse effects in INPP5F-null mice, unlike PTEN inhibitors .